Home
About
About Anagenics
Board of Directors
Divisions
Our Divisions
Beauty
Brands
évolis®
Uspa
Investors
Investor Centre
ASX Announcements
2024
2023
2022
2021
2020
2019
Financial Information & Reports
Share Registry Information
Analyst Coverage
Share Information
Anagenics in the media
Newsletter Archive
Corporate Governance
Corporate Governance
Board Charter
Code of Conduct
Policies
Audit Committee Charter
Nomination and Remuneration Committee Charter
Performance Evaluation Process
Corporate Code of Conduct
Environmental, Social and Governance Statement
✕
Financial News Feed Reports on Cellmid Limited
Home
Financial News Feed Reports on Cellmid Limited
November 15, 2019
Published by
Tiffany McMillan
on
November 15, 2019
Categories
Cellmid launches hair care products in Australia
November 15, 2019
Published by
Tiffany McMillan
on
November 15, 2019
Categories
CDY’s midkine antibody shown to accelerate bone fracture healing
November 15, 2019
Published by
Tiffany McMillan
on
November 15, 2019
Categories
New research backs CDY’s MK plan for osteoporosis
November 15, 2019
Published by
Tiffany McMillan
on
November 15, 2019
Categories
Cellmid MK antibodies effective in brain cancer trials
November 15, 2019
Published by
Tiffany McMillan
on
November 15, 2019
Categories
Cellmid records highest ever quarterly sales for Évolis®
November 15, 2019
Published by
Tiffany McMillan
on
November 15, 2019
Categories
Progress in bladder cancer monitoring bodes well for Cellmid
November 15, 2019
Published by
Tiffany McMillan
on
November 15, 2019
Categories
CDY awarded US patent for treatment of alopecia
November 15, 2019
Published by
Tiffany McMillan
on
November 15, 2019
Categories
Cellmid achieves record quarterly sales for its hair care products
